Abstract
What is tissue typing and how might it influence policy in relation to kidney transplantation? To answer these questions, some relationships between tissue matching, graft survival and function will be considered. Present policy and whether it could be improved will then be discussed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Counce, S., Smith, P., Barth, R. and Snell, G. D. (1956) Strong and weak histocompatibility gene differences in mice and their role in the rejection of homografts of tumours and skin. Ann. Surg., 144, 198–204
Breimer, M. W., Brynger, H., Le Pendu, J., Oriol, R., Rydberg, L., Samuelsson, B. E. and Vinas, J. (1987). Blood group ABO-incompatible kidney transplantation biochemical and immunochemical studies of blood group A glycolipid antigens in human kidney and characterization of the antibody response (antigen specificity and antibody class) in 0 recipients receiving A2 grafts. Transplant. Proc., 19, 226–230
Rydberg, L., Breimer, M. E., Samuelsson, B. E. and Brynger, H. (1987). Blood group ABO-incompatible (A2 to 0) kidney transplantation in human subjects: a clinical, serologic, and biochemical aproach. Transplant. Proc., 19, 4528–4537
Welsh, K. I., van Dam, M., Koffman, C. G., Bewick, M. E., Rudge, C. J., Tuabe, D. H. and Clark, A.G.B. (1987). Transplantation of blood group A2 kidneys into 0 or B recipients: the effect of pretransplant anti-A titers on graft survival Transplant. Proc., 19, 4565–4567
Shapira, Z., Yussim, A., Shmueli, D. and Nakache, R. (1987). Experience with blood group A2 renal grafts in ABO-incompatible recipients. Transplant Proc., 19, 4562–4564
Cook, D. J., Graver, B. and Terasaki, P. I. (1987). ABO incompatibility in cadaver donor kidney allografts. Transplant Proc., 19, 4549–4552
Ting, A. and Morris, P.J. (1983). Successful transplantation with a positive T and B cell crossmatch due to autoreactive antibodies. Tissue Antigens, 21, 219–226
Falk, J. A., Cardella, C. J., Halloran, P., Robinette, M., Arbus, G. and Bear, R. (1985). Transplantation can be performed with positive (noncurrent) crossmatch Transplant. Proc., 17, 1530–1532
Kerman, R. H., Flechner, S. M., Van Buren, C. T., Lorber, M. I. and Kahan, B. D. (1985). Successful transplantation of cyclosporine treated allograft recipients with serologically positive historical, but negative preoperative, donor crossmatches. Transplantation, 40, 615–619
Opelz, G. (1985). Correlation of HLA matching with kidney graft survival in patients with or without cyclosporine treatment. Transplantation, 40, 240–243
Terasaki, P. I., Toyotome, A., Mickey, M. R., Cicciarelli, J., Iwaki, Y., Cecka, M. and Tiwari, J. (1985). Patient, graft, and functional survival rates: an overview. In Terasali, P. I. (ed.) Clinical Kidney Transplants, Chapt. 1, pp. 1–26. (California: UCLA Tissue Typing Laboratory)
Salvatierra, O., Vicenti, F., Amend, W., Carovoy, M., Iwaki, Y., Terasaki, P., Potter, D., Duca, R., Hopper, S., Slemmer, T. and Feduska, N. (1983). Four-year experience with donor-specific blood transfusion. Transplant. Proc., 15, 924–931
Festenstein, H., Doyle, P. and Holmes, J. (1986). Long-term follow-up in London Transplant Group recipients of cadaver renal allografts. N. Engl. J. Med., 314, 7–13
Cecka, J. M. (1986). The changing role of HLA matching. In Terasaki, P. I. (ed.) Clinical Transplants, Chapt. 16, pp. 141–155. (California: UCLA Tissue Typing Laboratory)
Persijn, G. G., de Lange, P., D’Amaro, J., Cohen, B., Liebelt, P., Hendriks, G. F. J. and van Rood, J. J. (1986). Eurotransplant Part II. The cyclosporine era 1981–1985. In Terasaki, P.I. (ed.) Clinical Transplants, Chapt. 13, pp.99–107. (California: UCLA Tissue Typing Laboratory)
Chapman, J. R., Taylor, C., Ting, A. and Morris, P.J. (1986). Hyperacute rejection of a renal allograft in the presence of anti-CW5 antibody. Transplantation, 42, No. 1, 91–92
European Multicentre Trial Group (1983). Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial. Lancet, 2, 986–989
Madsen, M., Graugaard, B., Fjeldborg, O., Hansen, H. E., Posborg, V. and Kissmeyer-Nielsen (1985). The impact of HLA-DR antigen matching in cyclo-sporine-treated recipients of cadaveric renal allografts. A single-center analysis. Transplant. Proc., 17, No. 6, 2202–2204
Joysey, V. C., Thiru, S. and Evans, D. B. (1985). Effect of HLA-DR compatibility on kidney transplants treated with cyclosporine A. Transplant. Proc., 17, No. 6, 2187–2192
Gilks, W. R., Bradley, B. A., Gore, S. M. and Klouda, P. T. (1987). Substantial benefits of tissue matching in renal transplantation. Transplantation, 43, No. 5, 669–673
Opelz, G. (1988). Importance of HLA antigen splits for kidney transplant matching. Lancet, 2, 61–64
Opelz, G. (1987). Kidney transplantation in sensitized patients. Transplant. Proc., 19, No. 5, 3737–3741
Iwaki, Y. and Terasaki, P.I. (1986). Sensitization effect. In Terasaki, P.I. (ed.) Clinical Transplants, Chapt. 25, pp. 257–265. (California: UCLA Tissue Typing Laboratory)
Sanfilippo, F., Goeken, G., Niblack, G., Scornik, J. and Vaughn, W. K. (1987). The impact of HLA-A, B match of primary renal allografts subsequent to transplant failure. Transplant. Proc., 19, 669–671
Hendriks, G. F. J., Schreuder, G. M. Th., Claas, F. H. J., D’Amaro, J., Persijn, G. G., Cohen, B. and van Rood, J.J. (1983). HLA-DRw6 and renal allograft rejection. Br. Med. J., 286, 85–87
Hendriks, C. F. J., D’Amaro, J., Pensijn, G. G., Schreuder, G. M. T., Lansbergen, Q., Cohen, B. and van Rood, J. J. (1983). Excellent outcome after transplantation of renal allografts from HLA-DRw6 positive donors even in HLA-DR mismatches. Lancet, 2, 187–189
Vereerstraeten, P., Andrien, M., Dupont, E., De Pauw, L., Kinnaert, P. and Toussaint, C. (1987). Influence of donor and recipient DRw6 status on outcome of cadaver kidney transplantation. Transplant. Proc., 19, No. 1, 708–710
Cook, D. J. (1986). HLA-DR associated immune responsiveness. In Terasaki, P. I. (ed.) Clinical Transplants, Chapt. 24, pp. 247–256. (California: UCLA Tissue Typing Laboratory)
Smiley, M. L., Wlodaver, C. G., Grossman, R.A., Barker, C. F., Perloff, L. J., Tustin, N. B., Starr, S. E., Plotkin, S. A. and Friedman, H. M. (1985). The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation. Transplantation, 40, No. 2, 157–161
Grundy, J. E., Lui, S. F., Super, M., Berry, N. J., Sweny, P., Fernando, O. N., Moorhead, J. and Griffiths, P. D. (1988). Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet, 2, 132–135
Opelz, G. (1988). Allocation of cadaver kidneys for transplantation. Transplant. Proc., 20, No. 1, Suppl. 1, 1028–1032
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Joysey, V.C. (1989). Tissue Typing Policy. In: Catto, G.R.D. (eds) Transplantation. New Clinical Applications Nephrology, vol 9. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0855-0_3
Download citation
DOI: https://doi.org/10.1007/978-94-009-0855-0_3
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6872-7
Online ISBN: 978-94-009-0855-0
eBook Packages: Springer Book Archive